Hello everyone! Here is a long overdue update!
After plenty of hard work from both parties, the University of Alberta and NightstaRx have been able to finalize the research agreement necessary for this clinical trial to take place.
The brand new storage facility located on the University of Alberta campus and where the viral vector will be stored, has been validated and will be ready for the start of the trial.
Final pre-trial training requirements for the research team members have been scheduled.
Though delayed by a few months, patient selection is now well underway. We will be recruiting six patients in 2015. Patients who have already been in contact with us will be informed whether or not they are selected for this trial once this process is complete.